PowerUp Acquisition (PWUP) Competitors $11.50 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PWUP vs. CTNM, AMLX, ALEC, QTTB, KMDA, BTMD, DSGN, CYRX, ACIU, and JSPRShould you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include Contineum Therapeutics (CTNM), Amylyx Pharmaceuticals (AMLX), Alector (ALEC), Q32 Bio (QTTB), Kamada (KMDA), biote (BTMD), Design Therapeutics (DSGN), Cryoport (CYRX), AC Immune (ACIU), and Jasper Therapeutics (JSPR). These companies are all part of the "pharmaceutical products" industry. PowerUp Acquisition vs. Contineum Therapeutics Amylyx Pharmaceuticals Alector Q32 Bio Kamada biote Design Therapeutics Cryoport AC Immune Jasper Therapeutics Contineum Therapeutics (NASDAQ:CTNM) and PowerUp Acquisition (NASDAQ:PWUP) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, community ranking, media sentiment, analyst recommendations, risk, dividends and valuation. Do insiders & institutionals have more ownership in CTNM or PWUP? 19.2% of PowerUp Acquisition shares are owned by institutional investors. 48.0% of PowerUp Acquisition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, CTNM or PWUP? Contineum Therapeutics has higher revenue and earnings than PowerUp Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioContineum Therapeutics$50M7.04$22.72MN/AN/APowerUp AcquisitionN/AN/AN/AN/AN/A Do analysts prefer CTNM or PWUP? Contineum Therapeutics presently has a consensus target price of $29.25, suggesting a potential upside of 114.13%. Given Contineum Therapeutics' stronger consensus rating and higher probable upside, equities analysts clearly believe Contineum Therapeutics is more favorable than PowerUp Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Contineum Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20PowerUp Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in CTNM or PWUP? Contineum Therapeutics received 7 more outperform votes than PowerUp Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformContineum TherapeuticsOutperform Votes7100.00% Underperform VotesNo VotesPowerUp AcquisitionN/AN/A Is CTNM or PWUP more profitable? PowerUp Acquisition's return on equity of 0.00% beat Contineum Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Contineum TherapeuticsN/A -49.92% -20.52% PowerUp Acquisition N/A N/A N/A Does the media refer more to CTNM or PWUP? In the previous week, Contineum Therapeutics had 2 more articles in the media than PowerUp Acquisition. MarketBeat recorded 2 mentions for Contineum Therapeutics and 0 mentions for PowerUp Acquisition. Contineum Therapeutics' average media sentiment score of 0.03 beat PowerUp Acquisition's score of 0.00 indicating that Contineum Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Contineum Therapeutics Neutral PowerUp Acquisition Neutral SummaryContineum Therapeutics beats PowerUp Acquisition on 8 of the 12 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get PowerUp Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for PWUP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PWUP vs. The Competition Export to ExcelMetricPowerUp AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$89.36M$261.73M$108.28M$8.80BDividend YieldN/A7.57%5.20%4.07%P/E RatioN/A2.161.0713.60Price / SalesN/A155.741.1687.40Price / CashN/A80.91100.1736.27Price / BookN/A73.36519.866.33Net IncomeN/A$32.24M$2.82M$225.93M7 Day Performance-0.80%-0.40%-0.41%-0.96%1 Month Performance-11.54%-4.95%-3.37%1.06%1 Year Performance5.80%14.10%15.45%26.59% PowerUp Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PWUPPowerUp AcquisitionN/A$11.50flatN/AN/A$89.36MN/A0.00N/ACTNMContineum Therapeutics1.6433 of 5 stars$13.66+0.1%$29.25+114.1%N/A$352.16M$50M0.0031AMLXAmylyx Pharmaceuticals4.3626 of 5 stars$5.09-2.7%$11.43+124.5%-59.5%$348.92M$380.79M0.00200Analyst UpgradeALECAlector4.3736 of 5 stars$3.54-2.5%$20.67+483.8%-26.1%$346.67M$97.06M-2.14270Positive NewsQTTBQ32 Bio1.6142 of 5 stars$28.00+2.6%$72.33+158.3%N/A$341.04M$1.16M0.0039KMDAKamada3.8063 of 5 stars$5.83+0.2%$14.50+148.7%+23.3%$335.11M$142.52M20.79360Analyst RevisionBTMDbiote3.1975 of 5 stars$5.97-1.5%$8.39+40.5%+19.8%$323.69M$185.36M23.31194DSGNDesign Therapeutics1.7541 of 5 stars$5.66+3.3%$7.00+23.7%+145.7%$320.47MN/A0.0040CYRXCryoport2.8991 of 5 stars$6.46-1.7%$12.50+93.5%-52.6%$319.32M$233.26M-1.941,170Insider TradeACIUAC Immune2.3118 of 5 stars$3.22-0.6%$12.00+272.7%+0.0%$318.59M$16.48M0.00140Positive NewsJSPRJasper Therapeutics2.6633 of 5 stars$21.18+1.0%$74.86+253.4%+227.3%$317.70MN/A0.0020 Related Companies and Tools Related Companies CTNM Competitors AMLX Competitors ALEC Competitors QTTB Competitors KMDA Competitors BTMD Competitors DSGN Competitors CYRX Competitors ACIU Competitors JSPR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PWUP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PowerUp Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share PowerUp Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.